![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|16|29|3317-3326
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.16, Iss.29, 2010-10, pp. : 3317-3326
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer
Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Carbonic Anhydrase Activation and the Drug Design
Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-03 ,pp. :